Darunavir + Lamivudine + Tenofovir Disoproxil Fumarate
Composition
The formulation contains Darunavir 50mg + Tenofovir Disoproxil Fumarate 300mg + Lamivudine 300mg Tablet: Contains darunavir 50mg, tenofovir disoproxil fumarate 300mg, and lamivudine 300mg as the active ingredients.
Indications
Treatment of HIV-1 infection in adults and adolescents
Side effects
Nausea, diarrhea, jaundice, rash
Precautions
Monitor liver function, renal function, and signs of infection
Contraindications
Severe hepatic impairment, hypersensitivity to any of the components
Dosage and administration
One tablet once daily with food
Countries
Brazil, India, Europe
Available Forms
Tablets